Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma

Vittoria Rufini; Giorgio Treglia; Paola Castaldi; Germano Perotti; Maria Lucia Calcagni; Salvatore Maria Corsello; G Galli; Silvia Fanti; Aldo Giordano

doi:10.1097/MNM.0b013e328345a340

Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma

Vittoria Rufini, Giorgio Treglia, Paola Castaldi, Germano Perotti, Maria Lucia Calcagni, Salvatore Maria Corsello, G Galli, Silvia Fanti, Aldo Giordano

Risultato della ricerca: Contributo in rivista › Articolo in rivista

42 Citazioni (Scopus)

Abstract

Detection of recurrent disease is essential for treatment planning in patients with paraganglioma. The aim of this study was to compare 123I-metaiodobenzylguanidine (123I-MIBG) scintigraphy [whole-body and single-photon emission computed tomography (SPECT) computed tomography (CT) scanning] and fluorine-18-L-dihydroxyphenylalanine positron emission tomography CT (18F-DOPA PET-CT) in the re-staging of patients with known or suspected recurrent paraganglioma.

Lingua originale	English
pagine (da-a)	575-582
Numero di pagine	8
Rivista	Nuclear Medicine Communications
Volume	32
DOI	https://doi.org/10.1097/MNM.0b013e328345a340
Stato di pubblicazione	Pubblicato - 2011

Keywords

3-Iodobenzylguanidine
Adrenal Gland Neoplasms
Adult
Aged
Dihydroxyphenylalanine
Female
Humans
Male
Middle Aged
Neoplasm Staging
Paraganglioma
Paraganglioma, Extra-Adrenal
Pheochromocytoma
Positron-Emission Tomography
Recurrence
Retrospective Studies
Tomography, Emission-Computed, Single-Photon
Tomography, X-Ray Computed
Young Adult

Accesso al documento

10.1097/MNM.0b013e328345a340

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{31e7647603ed480b993480a66bbf12dd,

title = "Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma",

abstract = "Detection of recurrent disease is essential for treatment planning in patients with paraganglioma. The aim of this study was to compare 123I-metaiodobenzylguanidine (123I-MIBG) scintigraphy [whole-body and single-photon emission computed tomography (SPECT) computed tomography (CT) scanning] and fluorine-18-L-dihydroxyphenylalanine positron emission tomography CT (18F-DOPA PET-CT) in the re-staging of patients with known or suspected recurrent paraganglioma.",

keywords = "3-Iodobenzylguanidine, Adrenal Gland Neoplasms, Adult, Aged, Dihydroxyphenylalanine, Female, Humans, Male, Middle Aged, Neoplasm Staging, Paraganglioma, Paraganglioma, Extra-Adrenal, Pheochromocytoma, Positron-Emission Tomography, Recurrence, Retrospective Studies, Tomography, Emission-Computed, Single-Photon, Tomography, X-Ray Computed, Young Adult, 3-Iodobenzylguanidine, Adrenal Gland Neoplasms, Adult, Aged, Dihydroxyphenylalanine, Female, Humans, Male, Middle Aged, Neoplasm Staging, Paraganglioma, Paraganglioma, Extra-Adrenal, Pheochromocytoma, Positron-Emission Tomography, Recurrence, Retrospective Studies, Tomography, Emission-Computed, Single-Photon, Tomography, X-Ray Computed, Young Adult",

author = "Vittoria Rufini and Giorgio Treglia and Paola Castaldi and Germano Perotti and Calcagni, {Maria Lucia} and Corsello, {Salvatore Maria} and G Galli and Silvia Fanti and Aldo Giordano",

year = "2011",

doi = "10.1097/MNM.0b013e328345a340",

language = "English",

volume = "32",

pages = "575--582",

journal = "Nuclear Medicine Communications",

issn = "0143-3636",

publisher = "Lippincott Williams and Wilkins Ltd.",

}

TY - JOUR

T1 - Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma

AU - Rufini, Vittoria

AU - Treglia, Giorgio

AU - Castaldi, Paola

AU - Perotti, Germano

AU - Calcagni, Maria Lucia

AU - Corsello, Salvatore Maria

AU - Galli, G

AU - Fanti, Silvia

AU - Giordano, Aldo

PY - 2011

Y1 - 2011

N2 - Detection of recurrent disease is essential for treatment planning in patients with paraganglioma. The aim of this study was to compare 123I-metaiodobenzylguanidine (123I-MIBG) scintigraphy [whole-body and single-photon emission computed tomography (SPECT) computed tomography (CT) scanning] and fluorine-18-L-dihydroxyphenylalanine positron emission tomography CT (18F-DOPA PET-CT) in the re-staging of patients with known or suspected recurrent paraganglioma.

AB - Detection of recurrent disease is essential for treatment planning in patients with paraganglioma. The aim of this study was to compare 123I-metaiodobenzylguanidine (123I-MIBG) scintigraphy [whole-body and single-photon emission computed tomography (SPECT) computed tomography (CT) scanning] and fluorine-18-L-dihydroxyphenylalanine positron emission tomography CT (18F-DOPA PET-CT) in the re-staging of patients with known or suspected recurrent paraganglioma.

KW - 3-Iodobenzylguanidine

KW - Adrenal Gland Neoplasms

KW - Adult

KW - Aged

KW - Dihydroxyphenylalanine

KW - Female

KW - Humans

KW - Male

KW - Middle Aged

KW - Neoplasm Staging

KW - Paraganglioma

KW - Paraganglioma, Extra-Adrenal

KW - Pheochromocytoma

KW - Positron-Emission Tomography

KW - Recurrence

KW - Retrospective Studies

KW - Tomography, Emission-Computed, Single-Photon

KW - Tomography, X-Ray Computed

KW - Young Adult

KW - 3-Iodobenzylguanidine

KW - Adrenal Gland Neoplasms

KW - Adult

KW - Aged

KW - Dihydroxyphenylalanine

KW - Female

KW - Humans

KW - Male

KW - Middle Aged

KW - Neoplasm Staging

KW - Paraganglioma

KW - Paraganglioma, Extra-Adrenal

KW - Pheochromocytoma

KW - Positron-Emission Tomography

KW - Recurrence

KW - Retrospective Studies

KW - Tomography, Emission-Computed, Single-Photon

KW - Tomography, X-Ray Computed

KW - Young Adult

UR - http://hdl.handle.net/10807/5498

U2 - 10.1097/MNM.0b013e328345a340

DO - 10.1097/MNM.0b013e328345a340

M3 - Article

SN - 0143-3636

VL - 32

SP - 575

EP - 582

JO - Nuclear Medicine Communications

JF - Nuclear Medicine Communications

ER -

Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo